Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001339970-25-000011
Filing Date
2025-08-07
Accepted
2025-08-07 16:19:07
Documents
22

Document Format Files

Seq Description Document Type Size
1 S-3 atyr-20250807.htm S-3 603397
2 EX-4.9 atyr-ex4_9.htm EX-4.9 490483
3 EX-4.12 atyr-ex4_12.htm EX-4.12 206059
4 EX-4.13 atyr-ex4_13.htm EX-4.13 248452
5 EX-4.14 atyr-ex4_14.htm EX-4.14 171395
6 EX-5.1 atyr-ex5_1.htm EX-5.1 56313
7 EX-23.1 atyr-ex23_1.htm EX-23.1 3810
8 EX-FILING FEES atyr_exfilingfees.htm   iXBRL EX-FILING FEES 86210
9 GRAPHIC img41057457_0.jpg GRAPHIC 16162
10 GRAPHIC img41057457_1.jpg GRAPHIC 16162
11 GRAPHIC img54294278_0.jpg GRAPHIC 90263
12 GRAPHIC img54294278_1.jpg GRAPHIC 90263
  Complete submission text file 0001339970-25-000011.txt   2298941

Data Files

Seq Description Document Type Size
25 EXTRACTED XBRL INSTANCE DOCUMENT atyr_exfilingfees_htm.xml XML 12145
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-289360 | Film No.: 251194361
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)